Mannitol opening of the blood-brain barrier: Regional variation in the permeability of sucrose, but not 86Rb+ or albumin

Brain Research

Volumn 1014, Issue 1-2, 2004, Pages 221-227

  Brown, Rachel C ^a,b   Egleton, Richard D ^a   Davis, Thomas P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Disorders of the nervous systems; Hyperosmolar mannitol; In situ perfusion; Neuro oncology; Permeability; Tight junction

Indexed keywords

ALBUMIN; EVANS BLUE; MANNITOL; POTASSIUM ION; RUBIDIUM 86; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DRUG PENETRATION; FEMALE; HYPEROSMOLALITY; ION PERMEABILITY; MESENCEPHALON; NONHUMAN; PERFUSION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT;

ALBUMINS; ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN STEM; CEREBELLUM; CEREBRAL CORTEX; EVANS BLUE; FEMALE; MANNITOL; MESENCEPHALON; MOLECULAR WEIGHT; ORGAN SIZE; OSMOLAR CONCENTRATION; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; RUBIDIUM RADIOISOTOPES; SUCROSE;

EID: 2942735000     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.04.034     Document Type: Article

References (32)

1. Abbruscato T.J., Davis T.P. Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity. J. Pharmacol. Exp. Ther. 289:1999;668-675
2. Belayev L., Busto R., Zhao W., Ginsberg M.D. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739:1996;88-96
3. Bhattacharjee A.K., Nagashima T., Kondoh T., Tamaki N. Quantification of early blood-brain barrier disruption by in situ brain perfusion technique. Brain Res. Brain Res. Protoc. 8:2001;126-131
4. Brown R.C., Mark K.S., Egleton R.D., Huber J.D., Burroughs A., Davis T.P. Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFκB. J. Cell. Sci. 116(Pt 4):2003;693-700
5. Doolittle N.D., Petrillo A., Bell S., Cummings P., Eriksen S. Blood-brain barrier disruption for the treatment of malignant brain tumors: the national program. J. Neurosci. Nurs. 30:1998;81-90
6. Doolittle N.D., Miner M.E., Hall W.A., Siegal T., Hanson E.J., Osztie E., McAllister L.D., Bubalo J.S., Kraemer D.F., Fortin D., Nixon R., Muldoon L.L., Neuwelt E.A. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer. 88:2000;637-647
7. Egleton R.D., Abbruscato T.J., Thomas S.A., Davis T.P. Transport of opioid peptides into the central nervous system. J. Pharm. Sci. 87:1998;1433-1439
8. Gumerlock M.K., Belshe B.D., Madsen R., Watts C. Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review. J. Neuro-oncol. 12:1992;33-46
9. Gurwel M., Culic O., Muhs A., Williams J., Schrader J. Regulation of endothelial Na+-K+-ATPase activity by cAMP. Biochem. Biophys. Res. Commun. 242:1998;93-97
10. Haas M. The Na-K-Cl cotransporters. Am. J. Physiol., Cell Physiol. 267:1994;C869-C885
11. Hawkins C.P., Mackenzie F., Tofts P., du Boulay E.P., McDonald W.I. Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain Res. 114:1991;801-810
12. Hom S., Egleton R.D., Huber J.D., Davis T.P. Effect of reduced flow on blood-brain barrier transport systems. Brain Res. 890:2001;38-48
13. Huber J.D., Egleton R.D., Davis T.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24:2001;719-725
14. Huber J.D., Witt K.A., Hom S., Egleton R.D., Mark K.S., Davis T.P. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol., Heart Circ. Physiol. 280:2001;H1241-H1248
15. Huber J.D., Hau V.S., Borg L., Campos C.R., Egleton R.D., Davis T.P. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. Am. J. Physiol., Heart Circ. Physiol. 283:2002;H1531-H1537
16. Kalaria R.N. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann. N.Y. Acad. Sci. 893:1999;113-125
17. Keep R.F., Xiang J., Betz A.L. Potassium transport at the blood-brain and blood-CSF barriers. Adv. Exp. Med. Biol. 331:1993;43-54
18. Kroll R.A., Neuwelt E.A. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery. 42:1998;1083-1100
19. Malek A.M., Goss G.G., Jiang L., Izumo S., Alper S.L. Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. Stroke. 29:1998;2631-2640
20. Mark K.S., Davis T.P. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am. J. Physiol., Heart Circ. Physiol. 282:2002;H1485-H1494
21. Merzak A., Pilkington G.J. Molecular and cellular pathology of intrinsic brain tumors. Can. Metas. Rev. 16:1997;155-177
22. Mooradian A.D. Effect of aging on the blood-brain barrier. Neurobiol. Aging. 9:1988;31-39
23. Murphy C.L., Lever M.J. A ratiometric method of autofluorescence correction used for the quantification of Evans blue dye fluorescence in rabbit arterial tissues. Exp. Physiol. 87:2002;163-170
24. Nagashima T., Ikeda K., Wu S., Kondo T., Yamaguchi M., Tamaki N. The mechanism of reversible osmotic opening of the blood-brain barrier: role of intracellular calcium ion in capillary endothelial cells. Acta Neurochir., Suppl. 70:1997;231-233
25. Neuwelt E.A., Dahlborg S.A. Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases. J. Neuro-oncol. 4:1987;195-207
26. Neuwelt E.A., Hill S.A., Frenkel E.P. Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurgery. 15:1984;362-366
27. O'Donnell M.E., Martinez A., Sun D. Cerebral microvascular endothelial cell Na-K-Cl cotransport: regulation by astrocyte-conditioned medium. Am. J. Physiol. 268:1995;C747-C754
28. Paemeleire K., de Hemptinne A., Leybaert L. Chemically, mechanically, and hyperosmolarity-induced calcium responses of rat cortical capillary endothelial cells in culture. Exp. Brain Res. 126:1999;473-481
29. Plateel M., Teissier E., Cecchelli R. Hypoxia dramatically increases the nonspecific transport of blood-borne proteins to the brain. J. Neurochem. 68:1997;874-877
30. Stone L.A., Smith M.E., Albert P.S., Bash C.N., Maloni H., Frank J.A., McFarland H.F. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology. 45:1995;1122-1126
31. Stummer W., Keep R.F., Betz A.L. Rubidium entry into brain and cerebrospinal fluid during acute and chronic alterations in plasma potassium. Am. J. Physiol. 266:1994;H2239-H2246
32. Yang G.Y., Betz A.L. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke. 25:1994;1658-1664. (discussion 1664-5)